METOJECT 25
May 24, 2022
CLARISCAN 0.5
May 24, 2022
OMNISCAN 0.5
OMNISCAN is a gadoliniumbased contrast agent for diagnostic magnetic resonance imaging (MRI) indicated for intravenous use to:Visualize lesions with abnormal vascularity in the brain, spine, and associated tissues Facilitate the visualization of lesions with abnormal vascularity within the thoracic, abdominal, pelvic cavities, and the retroperitoneal space
Description
Indications:
- Treatment of active rheumatoid arthritis in adults
- Juvenile idiopathic arthritis
- Moderate to severe psoriasis and Severe psoriatic arthritis in adults
- Crohn's disease
Dosage:
Metoject PEN (methotrexate) must only be used once a week.Mechanism of action:
Methotrexate is a type of medicine called an immunosuppressant. It slows down your body's immune system and helps reduce inflammation.
Additional information
| Brand Name | |
|---|---|
| Generic Name | |
| Dosage Form | |
| Administration | |
| License Holder | |
| Key Ingredient |
OFFICE
No.27, Sharifi St. North Gandi Ave. Tehran,Iran.
Post Code: 1969813638
Tel: +98 21 88 650 472 4
Fax: +98 21 88 780 628
E-mail: info@ahranco.com
